FIGURE 2.
Combination of bicyclol and berberine demonstrates better therapeutic effects on NASH in mice induced by WD/CCl4. Male C57BL/6J mice were freely fed with Western diet plus intraperitoneal injection of 0.2 ml/kg CCl4 (WD/CCl4) once per week for 4 weeks (A). Liver steatosis was performed with H&E staining at week 4 (B). Then the mice were continuously treated with WD/CCl4 or WD/CCl4 plus drug for 8 weeks. The body weight (C) was recorded. ALT (D) and AST (E) in serum and TG (F) and CHO (G) in the liver were measured. Liver histopathology was evaluated using H&E, ORO, and Masson’s trichrome staining (H) and quantified with NAS score criteria (I) and fibrotic surface (J). Results were presented as mean ± SD. n = 5–9 for each group, *p < 0.05 and **p < 0.01, WD/CCl4-induced model group vs. the control group; #p < 0.05 and ##p < 0.01 vs. the WD/CCl4-induced model group or monotherapy group.